The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 18, 2025
Filed:
Feb. 04, 2019
Applicant:
Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA (US);
Inventors:
Sankaram Mantripragada, Windsor, CO (US);
Claude A. Piche, Verdun, CA;
Jo Jan Filip Van Betsbrugge, Laval, CA;
Assignee:
Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/26 (2006.01); A61K 9/00 (2006.01); A61K 9/14 (2006.01); A61K 31/724 (2006.01); A61K 47/12 (2006.01); A61K 47/24 (2006.01); A61M 15/00 (2006.01); A61M 15/08 (2006.01);
U.S. Cl.
CPC ...
A61K 38/26 (2013.01); A61K 9/0043 (2013.01); A61K 9/145 (2013.01); A61K 9/146 (2013.01); A61K 31/724 (2013.01); A61K 47/12 (2013.01); A61K 47/24 (2013.01); A61M 15/0065 (2013.01); A61M 15/08 (2013.01); A61M 2202/064 (2013.01);
Abstract
The present invention provides a powder formulation containing glucagon or a glucagon analog for nasal administration, useful in the treatment of hypoglycemia, and in particular the treatment of severe hypoglycemia. The present invention also provides a method of making this powder formulation, and to devices and methods for using the powder formulation.